CRS: BJMC
Position: Community Coordinator
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
